Enrolling by invitation NCT06916104
Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: search for respiratory allergies.
- Who it may be relevant to
- Registry conditions: Severe Asthma, Biotherapy, Respiratory Allergy. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.
Interventions
- Other search for respiratory allergies
analyses in terms of biotherapy and respiratory allergy
Primary outcome measures
- Find out whether a positive respiratory allergy test influences the efficacy of one or more biotherapies [Time frame: 1 year]
Secondary outcome measures (2)
- analyze the allergological workup, particularly with regard to common pneumallergens [Time frame: 1 year]
- look at the response to the biotherapy used [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Severe asthma patient on biotherapy
- Age > or = 18 years
- Follow-up at Poitiers University Hospital
Exclusion criteria
- Absence of allergological assessment
- Patient's refusal to participate in study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Chu Poitiers — Poitiers
Identifiers
NCT: NCT06916104 · IARBASP